Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$8.94 -0.29 (-3.20%)
As of: Oct 2, 2026 · 1:48 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Depreciation & Amortization (CF) (2011 - 2026)

Updated

Tonix Pharmaceuticals Holding's Depreciation & Amortization (CF) was $619,000 in Q2 2026, up 28.2% from $483,000 a year earlier and up 11.5% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Tonix Pharmaceuticals Holding's Depreciation & Amortization (CF) was $2.12 million through Jun 30, 2026, up 7.1% year-over-year; for FY2025, it was $1.93 million, down 43.7% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 134.8% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $3.42 million in FY2024 (-20.3%), $4.29 million in FY2023 (+242.5%), $1.25 million in FY2022 and $50,000 in FY2021 (+85.2%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) since Q2 2024.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in two of the last eight quarters, with an average decline of 26.0%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2022 (growth of 950.0%); the worst was Q4 2024 (a decline of 60.7%).
  • Per Business Quant data, TNXP's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $555,000 (Q1 2026), $488,000 (Q4 2025) and $461,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Tonix Pharmaceuticals Holding 163.56 Mn 163.56 Mn 12.84 Mn 619,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 619,000.00
Mar 31, 2026 555,000.00
Dec 31, 2025 488,000.00
Sep 30, 2025 461,000.00
Jun 30, 2025 483,000.00
Mar 31, 2025 493,000.00
Dec 31, 2024 496,000.00
Sep 30, 2024 510,000.00
Jun 30, 2024 1.21 Mn
Mar 31, 2024 1.21 Mn
Dec 31, 2023 1.26 Mn
Sep 30, 2023 1.22 Mn
Jun 30, 2023 900,000.00
Mar 31, 2023 893,000.00
Dec 31, 2022 836,000.00
Sep 30, 2022 252,000.00
Jun 30, 2022 102,000.00
Mar 31, 2022 63,000.00
Dec 31, 2021 27,000.00
Sep 30, 2021 10,000.00
API Access

Tonix Pharmaceuticals Holding Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TNXP&period=max&api_key=YOUR_API_KEY